(Press-News.org) ATLANTA -September 16, 2015- While cancer is the second leading cause of death overall in the United States, it remains the leading cause of death among U.S. Hispanics. The finding comes from "Cancer Statistics for Hispanics/Latinos," a comprehensive report produced every three years by the American Cancer Society and published in CA: A Cancer Journal for Clinicians.
Hispanics/Latinos represent the largest racial/ethnic minority group in the United States, accounting for 17.4% of the total U.S. population in 2014. In 2015, 125,900 new cancer cases and 37,800 cancer deaths are expected among Hispanics/Latinos in the U.S.
Lung cancer remains the leading cause of cancer death for Hispanic men, accounting for about one in six cancer deaths (17%). Based on the 2015 estimates, liver cancer is projected to surpass colorectal cancer as the second leading cause of cancer deaths among Hispanic men. Liver cancer incidence and death rates in Hispanic men and women are about double those in non-Hispanic whites.
Among Hispanic women, the leading cause of cancer death is breast cancer (16%), followed by lung and colorectal cancers. Lung cancer surpassed breast cancer as the leading cause of death among women overall in the U.S. in 1987. Lung cancer death rates in Hispanic women are 70% lower than those in non-Hispanic white women because of historically low smoking prevalence in Hispanic women. In 2014, 8% of Hispanic women smoked cigarettes compared to 17% of non-Hispanic white women.
Cancer death rates have been decreasing since 1995 in Hispanic men and since 1996 in Hispanic women, four years later than declines began in non-Hispanic whites. Cancer incidence rates among Hispanics/Latinos are dropping 2.4% per year in men and 0.5% per year in women, mirroring trends among non-Hispanic whites.
Overall, cancer incidence rates are 20% lower in Hispanics than in non-Hispanic whites and cancer death rates are 30% lower. This is mainly because Hispanics are less likely than non-Hispanic whites to be diagnosed with the four most common cancers (prostate, breast, lung, and colon). However, Hispanics have a higher risk of cancers associated with infectious agents, such as those of the stomach, liver, and cervix. For example, stomach and liver cancer incidence and death rates in Hispanics are double those in non-Hispanic whites.
The cancer profile of Hispanics/Latinos living in the U.S. is strikingly different from that for non-Hispanic whites and reflects the risk in countries of origin, particularly for more recent immigrants. For example, overall, death and incidence rates in Puerto Ricans and Cubans are more similar to those in non-Hispanic whites than in those of Mexican origin, who immigrated to the U.S. in large numbers more recently.
Hispanics are particularly vulnerable to cancer inequalities. They are generally less likely than non-Hispanic whites to be diagnosed at an early stage, especially for melanoma and female breast cancer. Although less access to high-quality care due to lower socioeconomic status contributes to this disparity, some studies have shown that Hispanics are at higher risk of advanced-stage disease even when socioeconomic status and health care access are similar.
"The growth in the population of U.S. residents of Hispanic origin is now driven primarily by births, not immigration, which will probably change the future cancer risk profile of this group" said Rebecca L. Siegel, MPH, director of surveillance information for the American Cancer Society and lead author of the report. "The second generation, born and raised in the U.S. and more intertwined in our lifestyle, including our diet, has higher cancer rates than first-generation immigrants, so we may see a higher cancer burden in this group in the future."
The authors say progress in cancer control in Hispanics/Latinos should include the use of culturally appropriate lay health advisors and patient navigators; targeted, community-based intervention programs to increase screening and vaccination and encourage healthy lifestyle behaviors; and further funding for research into cancer risk and prevention among specific subgroups in this population.
INFORMATION:
Article: Cancer Statistics for Hispanics/Latinos, 2015, CA Cancer J Clin 2015; doi: 10.3322/caac.21314
Authors are: Rebecca L. Siegel, MPH; Stacey A. Fedewa, MPH; Kimberly D. Miller, MPH; Ann Goding-Sauer, MPH; and Ahmedin Jemal, DVM, PhD, American Cancer Society; Paulo S. Pinheiro, MD, University of Nevada, Las Vegas, PhD; and Dinorah Martinez-Tyson, PhD, MPH, MA, University of South Florida.
DARIEN, IL - A new study of twins suggests that insomnia in adults is partially explained by genetic factors, and this heritability is higher in females than in males.
Results show that the genetic influences on insomnia symptoms in adults were substantial and largely stable over time while differing significantly by sex. In the longitudinal model, the estimated heritability of insomnia was 59 percent for females and 38 percent for males.
"This study indicates that genes may play a larger role in the development of insomnia symptoms for women than for men, providing ...
Female butterflies generally choose among male suitors, but in the tropics with hundreds of close relatives living in close proximity, how can they decide which males are the right ones? After all, if she mates with a male of another species, she is unlikely to have surviving offspring. One solution is that males of some species have scent producing organs on their wings, so if a male has the right smell, the female will presumably be receptive to his advances. Strangely, males of some species lack these scent producing organs, which would seem to be a huge disadvantage. ...
EAST LANSING, Mich. - Researchers at Michigan State University were part of a team to discover a new natural defense against HIV infection.
The team's discovery, featured in the current issue of the Journal of Biological Chemistry, focuses on ERManI, a protein that prevents the HIV virus from replicating.
"In earlier studies, we knew that we could interfere with the spread of HIV-1, but we couldn't identify the mechanism that was stopping the process," said Yong-Hui Zheng, MSU associate professor of microbiology and molecular genetics and co-author of the study. "We ...
NEW YORK - September 16, 2015 - EcoHealth Alliance, an environmental health nonprofit organization that focuses on local conservation and global health issues, announced the creation of the first centralized repository to collect data on the biological diversity in Bolivia. EcoHealth Alliance Senior Scientist, Carlos Zambrana-Torrelio, in collaboration with Miguel Fernandez from the German Centre for Integrative Biodiversity Research in coordination with more than 40 Bolivian scientists worked together to create the unique repository. The value of a biological repository ...
LAWRENCE -- A new study based on longitudinal data confirms a college degree provides an advantage in lifetimes earnings, but a related decision once students make it to college could prove to be even more crucial.
The study that includes a University of Kansas researcher found large lifetime earnings gaps depending on a student's field of study. For examples, men who major in science, technology, engineering and mathematics, or STEM fields, and earning a bachelor's degree achieved roughly $700,000 to $800,000 higher 40-year lifetime earnings from ages 20 to 59 than social ...
The incidence of the most common strain of Methicillin-resistant Staphylococcus aureus (MRSA) infections has decreased in hospital-onset cases, but has failed to decline in the broader community, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
The USA 300 strain of MRSA, has become prevalent in both communities and healthcare institutions. "In looking at risk factors for hospital or community-onset USA 300, current or former drug use was a strong predictor ...
Amsterdam, September 16, 2015 - Targeted cancer treatments, toxicity sensors and living factories: synthetic biology has the potential to revolutionize science and medicine. But before the technology is ready for real-world applications, more attention needs to be paid to its safety and stability, say experts in a review article published in Current Opinion in Chemical Biology.
Synthetic biology involves engineering microbes like bacteria to program them to behave in certain ways. For example, bacteria can be engineered to glow when they detect certain molecules, and ...
Washington -- A new analysis by the Synthetic Biology Project at the Wilson Center finds the Defense Department and its Defense Advanced Research Projects Agency (DARPA) funds much of the U.S. government's research in synthetic biology, with less than 1 percent of total federal funding going to risk research.
The report, U.S. Trends in Synthetic Biology Research, finds that between 2008 and 2014, the United States invested approximately $820 million dollars in synthetic biology research. In that time period, the Defense Department became a key funder of synthetic biology ...
The first true three-dimensional picture of submarine canyon habitats has been produced using a unique combination of marine robotics and ship-based measurements. The information captured in this new set of maps ranges in scale from the 200km canyon down to the size of an individual cold-water coral polyp, and will be used to inform the management of the only English Marine Conservation Zone in deep water.
This 'nested map' is the result of a recent scientific expedition to the Whittard Canyon in the Bay of Biscay, led by the National Oceanography Centre (NOC). It works ...
ROCHESTER, Minn. - Mayo Clinic researchers have identified a protein marker whose frequency may predict patient response to PD-1 blockade immunotherapy for melanoma. An abstract of their findings was presented today at the American Association for Cancer Research International Cancer Immunotherapy Conference in New York City.
"The discovery of biomarkers of sensitivity are vital not only for informing clinical decisions, but also to help identify which patients with melanoma, and possibly other malignancies, who are most likely to benefit from PD-1 blockade," says Roxana ...
